Cargando…

Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis

BACKGROUND: Fulminant myocarditis (FM) is a form of severe inflammatory carditis with rapidly developing acute heart failure. CASE PRESENTATION: We report three cases of successful intensive treatment by Impella of FM without any complications. In all cases, impairment of microcirculation as measure...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hori, Takayuki, Iida, Mitsuru, Uchiyama, Masateru, Shimokawa, Tomoki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004069/ https://www.ncbi.nlm.nih.gov/pubmed/35414115 http://dx.doi.org/10.1186/s13019-022-01821-x

Ejemplares similares

Enhanced recovery from fulminant myocarditis by treatment with the combined use of the Impella left ventricular assist device with extracorporeal membrane oxygenation: a case series
por: Nandate, Hideyuki, et al.
Publicado: (2022)

Surgical treatment of papillary fibroelastoma of the pulmonary valve: a case report
por: Uehara, Hiroo, et al.
Publicado: (2022)

Acute Fulminant Myocarditis Successfully Bridged to Recovery with Left Ventricular Assist Device and Complicated by Flail Mitral Valve
por: Duyuler, Pınar Türker, et al.
Publicado: (2016)

Successful Bridge-to-Recovery Treatment in a Young Patient with Fulminant Eosinophilic Myocarditis: Roles of a Percutaneous Ventricular Assist Device and Endomyocardial Biopsy
por: Hasegawa-Tamba, Saki, et al.
Publicado: (2019)

Fulminant Myocarditis Managed by Extracorporeal Life Support (Impella® CP): A Rare Case
por: Fox, Henrik, et al.
Publicado: (2017)

Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts
por: Tschöpe, Carsten, et al.
Publicado: (2018)

Acute hypoxemia caused by Impella in a patient with fulminant myocarditis and patent foramen ovale
por: Shibao, Kodai, et al.
Publicado: (2022)

Single vascular access for concomitant percutaneous coronary intervention and left ventricular assistance with Impella
por: Lyra, Flávio, et al.
Publicado: (2021)

Survey of Anticoagulation Practices with the Impella Percutaneous Ventricular Assist Device at High-Volume Centers
por: Reed, Brent N., et al.
Publicado: (2019)

COVID-19 fulminant myocarditis recovered with veno-arterial extracorporeal membrane oxygenation and Impella CP
por: Matsushita, Shunsuke, et al.
Publicado: (2023)

Surgical treatment of a huge hepatic artery aneurysm without revascularization—Case Report
por: Imazuru, Tomohiro, et al.
Publicado: (2018)

Novel Combination of Impella and Extra Corporeal Membrane Oxygenation as a Bridge to Full Recovery in Fulminant Myocarditis
por: Narain, Sachin, et al.
Publicado: (2012)

Recurrent Stress-Induced Cardiomyopathy With Cardiogenic Shock Requiring Impella Left Ventricular Assist Device
por: Feghaly, Julien, et al.
Publicado: (2021)

The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock
por: Ogawa, Shou, et al.
Publicado: (2019)

Primary malignant pericardial mesothelioma presenting with cardiac tamponade
por: Matsuyama, Shigefumi, et al.
Publicado: (2020)

A case of left ventricular free wall rupture after insertion of an IMPELLA® left ventricular assist device diagnosed by transesophageal echocardiography
por: Mizuno, Akito, et al.
Publicado: (2021)

Massive Biventricular Myocardial Calcification in a Patient with Fulminant Myocarditis Requiring Ventricular Assist Device Support
por: Kimura, Yuki, et al.
Publicado: (2018)

Fulminant Myocarditis After SARS-CoV-2 mRNA Vaccine Successfully Managed With Biventricular Impella Support: Multimodality Imaging Follow-Up
por: Ching, Shing, et al.
Publicado: (2022)

Implantation of Impella CP left ventricular assist device under the guidance of three-dimensional intracardiac echocardiography
por: Yastrebov, Konstantin, et al.
Publicado: (2020)

Single center first year experience and outcomes with Impella 5.5 left ventricular assist device
por: Rock, Joanna R., et al.
Publicado: (2022)

Myoglobin and left ventricular ejection fraction as predictive markers for death in children with fulminant myocarditis
por: Xie, Tingting, et al.
Publicado: (2022)

Successful bridge to recovery in fulminant myocarditis using a biventricular assist device: a case report
por: Adachi, Yusuke, et al.
Publicado: (2017)

Impella RP as a bridge to cardiac transplant for refractory late right ventricular failure in setting of left ventricular assist device
por: Randhawa, Varinder Kaur, et al.
Publicado: (2020)

Treatment of Fulminant Giant Cell Myocarditis Associated with Polymyositis Using a Left Ventricular Assist Device and Subsequent Corticosteroid and Immunosuppressive Therapy Leading to Remission
por: Ooka, Junichi, et al.
Publicado: (2017)

A successful case of patch angioplasty with bovine pericardium XenoSure® to the common femoral artery after endarterectomy
por: Uehara, Hiroo, et al.
Publicado: (2023)

Successful Management of Pheochromocytoma Crisis with Cardiogenic Shock by Percutaneous Left Ventricular Assist Device
por: Nakamura, Makiko, et al.
Publicado: (2022)

Publisher Correction: Implantation of Impella CP left ventricular assist device under the guidance of three-dimensional intracardiac echocardiography
por: Yastrebov, Konstantin, et al.
Publicado: (2021)

Left ventricular function changes and echocardiographic predictors in adult survivors of fulminant myocarditis treated with the Chinese protocol
por: Jiang, Luying, et al.
Publicado: (2023)

Severe Left Ventricular Failure Unmanageable by Impella 5.0
por: Mano, Akiko, et al.
Publicado: (2023)

Percutaneous approach to left ventricular assist device decommissioning
por: Moroni, Francesco, et al.
Publicado: (2022)

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock
por: Attinger-Toller, Adrian, et al.
Publicado: (2022)

A case of cardiogenic shock due to acute coronary syndrome successfully recovered by percutaneous and paracorporeal left ventricular assist device
por: Nakamura, Makiko, et al.
Publicado: (2019)

Clinical determinants of successful weaning from extracorporeal membrane oxygenation in patients with fulminant myocarditis
por: Matsumoto, Manabu, et al.
Publicado: (2018)

Percutaneous Salvage of an Impella Pretzel
por: Mathur, Moses, et al.
Publicado: (2019)

Successful Treatment of Fulminant Myocarditis with Intracardiac Thrombus in COVID-19
por: Mejia, E.J., et al.
Publicado: (2022)

Levitronix bilateral ventricular assist device, a bridge to recovery in a patient with acute fulminant myocarditis and concomitant cerebellar infarction
por: Yi-Fan, Huang, et al.
Publicado: (2018)

Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019)

Left Ventricular Mechanical Support with the Impella during Extracorporeal Membrane Oxygenation
por: Moazzami, Kasra, et al.
Publicado: (2017)

Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0opbqc2p2m4hd0nf93rcatdu88